Fenwick advised Shockwave Medical, Inc. on the deal. Shockwave Medical, Inc. (NASDAQ: SWAV), a medical device company focused on the development of Intravascular Lithotripsy (IVL) to...
Shockwave Medical’s Pending Acquisition of Neovasc
Belharra Therapeutics’ Multi-year Collaboration with Genentech
Fenwick represented Belharra Therapeutics on the deal. Belharra Therapeutics, a privately held drug discovery company with a novel photoaffinity-based, non-covalent chemoproteomics platform, announced its multi-year collaboration with...